The study aimed to assess how low-level alcohol consumption affects liver health in individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.
Evaluated liver health markers in patients with type 2 diabetes and MASLD
Assessed the impact of low-level alcohol intake
Utilized biochemical analyses to measure liver function
Lower alcohol intake associated with improved liver markers
80% of participants showed significant reduction in liver enzymes
Increased adherence to low alcohol consumption guidelines correlated with better liver health outcomes
Abstract
Objective: The study evaluated the impact of low-level alcohol intake on liver health in patients with type 2 diabetes (T2DM) and metabolic dysfunction–associated steatotic liver disease (MASLD).